metabolomics

The deal increases Metabolon's access to the European market and builds on its goal of bringing the value of metabolomics globally, according its CEO John Ryals.

Researchers from the US and UK used a combination of genetic and metabolomics analyses to home in on methylthioadenosine as sepsis biomarker.